El Os Formusols India Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 13-12-2024
- Paid Up Capital ₹ 5.00 M
as on 13-12-2024
- Company Age 24 Year, 6 Months
- Last Filing with ROC 31 Mar 2014
- Open Charges ₹ 10.33 Cr
as on 13-12-2024
- Satisfied Charges ₹ 0.30 M
as on 13-12-2024
About El Os Formusols India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2014. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹10.33 Cr. The company has closed loans amounting to ₹0.30 M, as per Ministry of Corporate Affairs (MCA) records.
Santhanam Jagan and Balan Venkaatesan serve as directors at the Company.
- CIN/LLPIN
U72200TZ2000PTC009420
- Company No.
009420
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Jul 2000
- Date of AGM
18 Aug 2014
- Date of Balance Sheet
31 Mar 2014
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Company Details
- Location
Coimbatore, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does El Os Formusols India Private Limited offer?
El Os Formusols India Private Limited offers a wide range of products and services, including .
Who are the key members and board of directors at El Os Formusols India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Santhanam Jagan  | Director | 12-Jul-2000 | Current |
| Balan Venkaatesan | Director | 12-Jul-2000 | Current |
Financial Performance of El Os Formusols India.
Enhance accessibility to El Os Formusols India's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of El Os Formusols India?
Unlock access to El Os Formusols India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Stanpro Pharmaceutical LimitedActive 35 years 4 monthsSanthanam Jagan and Balan Venkaatesan are mutual person
Charges (Loans)
₹10.33 Cr
₹0.03 Cr
Charges Breakdown by Lending Institutions
- Oriental Bank Of Commerce : 10.30 Cr
- State Bank Of Travancore : 0.03 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Aug 2009 | Oriental Bank Of Commerce | ₹10.30 Cr | Open |
| 11 Sep 2000 | State Bank Of Travancore | ₹0.30 M | Open |
| 08 Sep 2001 | State Bank Of Travancore | ₹0.30 M | Satisfied |
How Many Employees Work at El Os Formusols India?
Unlock and access historical data on people associated with El Os Formusols India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of El Os Formusols India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped El Os Formusols India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
